You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 84 No. 1, July 1961 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (6)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Evaluation of Flurandrenolone

A New Topical Corticosteroid

HOWARD R. GRAY, M.D.; ROBERT L. WOLF, M.D.; RONALD H. DONEFF, M.D.

Arch Dermatol. 1961;84(1):18-21.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Formula

Flurandrenolone* is a new corticosteroid which has a chemical formula of 6{alpha}-fluoro-16{alpha}-hydroxyhydrocortisone-16,17-acetonide. This new steroid is distinguished from hydrocortisone by the presence of 2 activityenhancing groupings, a 6{alpha}-fluorine and a 16{alpha}-OH. The structural formula follows:

Substitution of an alpha-fluorine atom for hydrogen at the sixth position and a hydroxyl group at the 16{alpha} position, as well as the acetonide function linkage at both the 16{alpha}- and 17{alpha}-hydroxyl groups, are new substituents designed to impart maximum potency as an anti-inflammatory agent. At the same time, the salt-retaining property of the parent compound is decreased.1

Pharmacological animal data by Kraay confirmed this increased potency and decreased sodium retention.2 Flurandrenolone was assayed using the standard methods of thymus involution and inhibition of granuloma formation around a cellulose pellet in adrenalectomized rats. On the basis of thymus involution, flurandrenolone appeared to have about 10 times the oral potency of prednisolone and from . . . [Full Text PDF of this Article]


Author Affiliations

INDIANAPOLIS

From the Department of Dermato-Syphilology, Marion County General Hospital (Chairman, Boynton H. Booth, M.D.).


Footnotes

Submitted for publication Feb. 27, 1961.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1961 American Medical Association. All Rights Reserved.